63 results
8-K
EX-4.2
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i
8-K
EX-4.3
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company
424B4
ji7tf3a
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
EX-3.1
trjq1lrp4n4rw2g
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-3.1
s92igl78tadhc3cc6stp
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:18pm
424B5
nffryf95u3
24 Mar 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-3.1
yv3 99fyp
6 Jan 22
Material Modifications to Rights of Security Holders
2:36pm